The signaling cascade can be disrupted by mutations in β-catenin itself, as well as by mutations in the destruction complex molecules or frizzled receptor leading to overexpression of S100A4 and increased invasiveness of the tumor. The gene discussed is S100A4; the disease is neoplasm.